Logo image of AGH

AUREUS GREENWAY HOLDINGS INC (AGH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AGH - US05156D1028 - Common Stock

5 USD
+0.1 (+2.04%)
Last: 12/4/2025, 8:03:35 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to AGH. AGH was compared to 132 industry peers in the Hotels, Restaurants & Leisure industry. While AGH has a great health rating, there are worries on its profitability. AGH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AGH has reported negative net income.
AGH had a negative operating cash flow in the past year.
AGH Yearly Net Income VS EBIT VS OCF VS FCFAGH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 200K 400K 600K 800K

1.2 Ratios

AGH has a worse Return On Assets (-3.72%) than 75.76% of its industry peers.
The Return On Equity of AGH (-4.30%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -3.72%
ROE -4.3%
ROIC N/A
ROA(3y)4.05%
ROA(5y)N/A
ROE(3y)17.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AGH Yearly ROA, ROE, ROICAGH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 40

1.3 Margins

The Gross Margin of AGH (48.29%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of AGH has declined.
The Profit Margin and Operating Margin are not available for AGH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5YN/A
AGH Yearly Profit, Operating, Gross MarginsAGH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 40

More info and screens

9

2. Health

2.1 Basic Checks

AGH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AGH has been reduced compared to 1 year ago.
AGH has a better debt/assets ratio than last year.
AGH Yearly Shares OutstandingAGH Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
AGH Yearly Total Debt VS Total AssetsAGH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M 4M 5M

2.2 Solvency

AGH has an Altman-Z score of 27.10. This indicates that AGH is financially healthy and has little risk of bankruptcy at the moment.
AGH has a better Altman-Z score (27.10) than 99.24% of its industry peers.
There is no outstanding debt for AGH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 27.1
ROIC/WACCN/A
WACC8.67%
AGH Yearly LT Debt VS Equity VS FCFAGH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200K 400K 600K 800K 1M

2.3 Liquidity

A Current Ratio of 6.89 indicates that AGH has no problem at all paying its short term obligations.
AGH has a better Current ratio (6.89) than 97.73% of its industry peers.
AGH has a Quick Ratio of 6.86. This indicates that AGH is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 6.86, AGH belongs to the best of the industry, outperforming 97.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.89
Quick Ratio 6.86
AGH Yearly Current Assets VS Current LiabilitesAGH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

AGH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -160.79%.
The Revenue has decreased by -7.21% in the past year.
Measured over the past years, AGH shows a quite strong growth in Revenue. The Revenue has been growing by 11.03% on average per year.
EPS 1Y (TTM)-160.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-7.21%
Revenue growth 3Y11.03%
Revenue growth 5YN/A
Sales Q2Q%-7.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AGH Yearly Revenue VS EstimatesAGH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 1M 2M 3M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AGH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AGH Price Earnings VS Forward Price EarningsAGH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AGH Per share dataAGH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AGH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AUREUS GREENWAY HOLDINGS INC

NASDAQ:AGH (12/4/2025, 8:03:35 PM)

5

+0.1 (+2.04%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.54%
Inst Owner Change160.26%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap75.30M
Revenue(TTM)3.03M
Net Income(TTM)-471.50K
AnalystsN/A
Price TargetN/A
Short Float %2.99%
Short Ratio0.89
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 24.88
P/FCF N/A
P/OCF N/A
P/B 6.87
P/tB 6.87
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.2
BVpS0.73
TBVpS0.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.72%
ROE -4.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.29%
FCFM N/A
ROA(3y)4.05%
ROA(5y)N/A
ROE(3y)17.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5YN/A
F-Score2
Asset Turnover0.24
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 231.58%
Cap/Sales 15.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.89
Quick Ratio 6.86
Altman-Z 27.1
F-Score2
WACC8.67%
ROIC/WACCN/A
Cap/Depr(3y)111.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.94%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-160.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.21%
Revenue growth 3Y11.03%
Revenue growth 5YN/A
Sales Q2Q%-7.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-171.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-106.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89.42%
OCF growth 3Y-38.05%
OCF growth 5YN/A

AUREUS GREENWAY HOLDINGS INC / AGH FAQ

What is the ChartMill fundamental rating of AUREUS GREENWAY HOLDINGS INC (AGH) stock?

ChartMill assigns a fundamental rating of 3 / 10 to AGH.


What is the valuation status of AUREUS GREENWAY HOLDINGS INC (AGH) stock?

ChartMill assigns a valuation rating of 0 / 10 to AUREUS GREENWAY HOLDINGS INC (AGH). This can be considered as Overvalued.


How profitable is AUREUS GREENWAY HOLDINGS INC (AGH) stock?

AUREUS GREENWAY HOLDINGS INC (AGH) has a profitability rating of 1 / 10.